Nilotinib Drug Interactions: 673 Major, 396 Moderate
Nilotinib Drug Interactions
Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Nilotinib. Always confirm against the full prescribing information.
100 interactions
Abacavir
The metabolism of Abacavir can be decreased when combined with Nilotinib.
Level 2 evidence
Abemaciclib
The metabolism of Abemaciclib can be decreased when combined with Nilotinib.
Level 1 evidence
Acarbose
The therapeutic efficacy of Acarbose can be decreased when used in combination with Nilotinib.
Level 2 evidence
Acitretin
Acitretin may increase the hepatotoxic activities of Nilotinib.
Level 2 evidence
Acoramidis
The metabolism of Acoramidis can be decreased when combined with Nilotinib.
Level 2 evidence
Acrivastine
The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Nilotinib.
Level 2 evidence
Adagrasib
The serum concentration of Adagrasib can be increased when it is combined with Nilotinib.
Level 1 evidence
Afatinib
The serum concentration of Afatinib can be increased when it is combined with Nilotinib.
Level 2 evidence
Albuterol
The risk or severity of QTc prolongation can be increased when Salbutamol is combined with Nilotinib.
Level 2 evidence
Allopurinol
The risk or severity of adverse effects can be increased when Allopurinol is combined with Nilotinib.
Level 1 evidence
Almotriptan
The metabolism of Almotriptan can be decreased when combined with Nilotinib.
Level 1 evidence
Alpelisib
The serum concentration of Alpelisib can be increased when it is combined with Nilotinib.
Level 1 evidence
Enter your NPI to unlock 44 major interactions for Nilotinib
Nilotinib has 1243 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Nilotinib has 673 major, 396 moderate, and 174 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Nilotinib. Always confirm against the full prescribing information.